data_1gjh_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1gjh _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.848 0.356 . . . . 11.619999999999999 111.227 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -179.09 74.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 7.3799999999999999 111.173 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 48.03 -168.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.825 -0.702 . . . . 5.2800000000000002 112.597 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.59 31.15 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.748 0.308 . . . . 8.25 110.867 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 10.7 p -101.67 -51.19 3.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 4.0999999999999996 110.9 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.42 33.53 5.08 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.758 -0.734 . . . . 2.79 112.547 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.419 ' HB3' ' CD1' ' A' ' 195' ' ' TRP . 30.7 m-85 -48.61 144.55 4.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 2.3599999999999999 110.822 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -150.4 113.81 4.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 1.9099999999999999 110.989 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASN . . . . . . . . . . . . . 2.4 p30 -47.52 -30.77 3.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 2.29 111.023 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -69.39 -44.41 71.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.283 -0.417 . . . . 3.73 110.728 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -70.4 -41.24 73.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 2.4399999999999999 110.733 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ILE . . . . . 0.453 ' CD1' ' CZ2' ' A' ' 195' ' ' TRP . 1.7 mt -56.24 -52.07 55.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 1.46 111.218 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 41.3 t -65.63 -38.05 81.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 1.1299999999999999 111.072 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.1 mmt -57.74 -51.19 70.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.351 -0.386 . . . . 1.3300000000000001 110.861 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . 0.451 ' CE ' ' CG ' ' A' ' 94' ' ' HIS . 0.7 OUTLIER -63.32 -45.15 92.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 2.4900000000000002 110.991 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -59.77 -61.7 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 2.0800000000000001 110.678 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ILE . . . . . . . . . . . . . 92.8 mt -51.62 -45.48 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 1.2 110.819 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -44.84 -66.23 0.42 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.853 -0.612 . . . . 1.01 110.945 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -49.13 -38.27 24.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 0.93999999999999995 110.398 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -58.87 -29.2 66.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 2.4500000000000002 110.73 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -89.87 -46.97 8.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 1.3700000000000001 109.933 179.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.74 -25.67 11.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 1.8400000000000001 110.913 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.88 -42.72 68.95 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.075 0.464 . . . . 2.7999999999999998 109.76 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -85.11 -46.28 11.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.694 -0.685 . . . . 3.3700000000000001 110.578 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.55 -2.93 6.14 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.631 -0.795 . . . . 0.98999999999999999 113.475 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . 0.421 ' CZ ' ' HA ' ' A' ' 30' ' ' TRP . 1.2 t80 -68.5 109.26 3.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.117 0.459 . . . . 2.4199999999999999 110.609 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -66.35 83.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.986 -0.552 . . . . 2.5800000000000001 111.373 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TRP . . . . . 0.421 ' HA ' ' CZ ' ' A' ' 28' ' ' TYR . 14.0 t90 -59.91 124.5 20.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.065 -0.516 . . . . 0.84999999999999998 110.719 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -86.43 59.32 5.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.414 . . . . 2.8199999999999998 110.851 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.88 -54.19 16.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 1.49 111.182 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.33 68.91 3.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.704 -0.76 . . . . 3.27 112.496 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.64 -32.31 12.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 6.3899999999999997 110.888 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.55 74.63 6.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 7.25 110.863 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 13.3 p -88.26 55.63 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 6.5800000000000001 111.102 179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -110.42 37.81 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 7.9100000000000001 110.991 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 43.48 85.87 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.022 -0.535 . . . . 9.2599999999999998 111.382 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -102.17 91.04 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 9.0600000000000005 110.896 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.97 57.11 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 9.4900000000000002 110.939 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.86 -78.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 7.5 110.836 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.4 31.99 5.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 9.0999999999999996 110.945 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . 68.76 151.4 0.13 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 6.8099999999999996 111.234 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.56 -26.47 19.86 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.766 2.31 . . . . 6.4500000000000002 112.448 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -47.7 115.53 1.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.367 -0.379 . . . . 7.5700000000000003 111.051 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.77 52.82 0.53 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.778 -0.725 . . . . 3.8700000000000001 112.434 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.5 p -47.38 -31.65 4.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 4.1500000000000004 111.111 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.97 -73.17 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 3.5099999999999998 110.887 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.403 ' O ' ' CD2' ' A' ' 94' ' ' HIS . 47.3 p -77.89 7.39 6.02 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.035 0.754 . . . . 1.8600000000000001 113.035 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.07 -48.69 13.9 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.288 -0.634 . . . . 2.2799999999999998 109.288 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 7.5 p -50.36 -33.67 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.057 -0.974 . . . . 2.1000000000000001 110.545 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.9 t -75.12 -43.64 44.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.68 -0.691 . . . . 1.1899999999999999 111.202 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . 0.451 ' CG ' ' CE ' ' A' ' 17' ' ' LYS . 51.5 m-70 -54.08 -60.63 3.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.958 0.409 . . . . 1.9199999999999999 110.581 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LEU . . . . . . . . . . . . . 3.0 mt -47.96 -32.36 6.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.954 -0.567 . . . . 2.71 110.963 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.4 ' CG2' ' CE2' ' A' ' 198' ' ' PHE . 3.1 m -74.32 -57.58 3.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 1.6100000000000001 111.002 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.4 -60.31 3.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.344 -0.389 . . . . 1.27 111.034 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.62 -57.47 8.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 3.7400000000000002 110.967 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -59.7 -61.35 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 2.73 110.992 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.93 -61.1 2.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 1.45 111.237 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . -44.51 -50.75 8.12 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.144 -0.55 . . . . 1.24 113.198 -179.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -63.91 -27.88 69.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.076 0.438 . . . . 2.1800000000000002 110.272 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.57 -43.16 77.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.089 -0.505 . . . . 1.8899999999999999 110.645 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 108' ' ' TYR . 15.6 t80 -60.28 -61.65 2.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.965 -0.561 . . . . 2.1299999999999999 110.508 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -39.49 17.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 1.6499999999999999 110.785 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.54 -34.42 70.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 3.8900000000000001 110.562 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -75.93 -15.94 60.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.966 -0.561 . . . . 4.25 111.52 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' TYR . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 104' ' ' PHE . 81.3 m-85 -114.72 97.58 6.35 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.764 0.316 . . . . 3.3599999999999999 110.9 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -43.39 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 5.0899999999999999 110.898 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.58 99.24 6.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 5.2199999999999998 110.92 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.87 -50.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 2.6200000000000001 110.959 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' PHE . . . . . 0.405 ' CE2' ' HB2' ' A' ' 153' ' ' PHE . 8.0 m-85 -102.64 -30.78 10.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 2.1200000000000001 110.955 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -82.47 -54.25 5.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 1.27 110.926 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -50.9 -31.58 17.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 2.54 110.889 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 41.7 ttp -78.75 -32.73 46.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 1.45 110.858 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.1 t -48.97 -31.81 8.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 1.95 110.902 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.7 t -48.6 -31.98 7.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 2.3799999999999999 110.901 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -90.55 57.82 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 2.8700000000000001 110.824 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -148.3 85.35 1.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 2.0699999999999998 110.867 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -51.02 137.5 21.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 4.3600000000000003 110.969 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.3 101.48 12.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 2.75 110.895 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -162.91 152.08 12.67 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 2.0499999999999998 110.819 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.22 62.65 2.04 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.739 2.292 . . . . 1.9199999999999999 112.373 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -177.69 149.42 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 4.6900000000000004 110.858 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 63.9 p 48.5 31.0 2.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 2.8599999999999999 110.883 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.7 -46.0 48.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 1.3799999999999999 111.044 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -76.76 -31.76 57.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 3.0800000000000001 110.879 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.34 -31.27 78.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.713 -0.756 . . . . 0.48999999999999999 112.503 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 16.9 mmt85 -83.74 -31.68 25.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.858 0.361 . . . . 3.48 110.873 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -66.7 -46.67 74.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 1.96 110.795 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . 0.45 ' N ' ' CD1' ' A' ' 130' ' ' PHE . . . -56.97 -40.49 76.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 1.04 111.112 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.44 -34.58 75.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 1.0600000000000001 111.105 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 25.8 t -70.66 -53.67 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 1.1899999999999999 111.351 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.434 HG12 ' CZ ' ' A' ' 180' ' ' TYR . 4.9 t -65.48 -29.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 1.1100000000000001 111.272 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.08 -42.7 99.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.913 0.387 . . . . 2.0299999999999998 110.178 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.54 -33.71 74.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.042 -0.526 . . . . 2.29 110.389 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -56.33 -49.55 74.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 1.3600000000000001 110.233 179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.41 ' CD2' HG11 ' A' ' 142' ' ' VAL . 9.3 m-85 -112.23 66.17 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.066 -0.516 . . . . 1.8100000000000001 110.95 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -60.76 2.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 4.4500000000000002 110.876 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -80.88 -74.76 0.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 2.8399999999999999 110.975 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -134.35 169.09 23.19 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 1.3500000000000001 112.521 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' VAL . . . . . 0.41 HG11 ' CD2' ' A' ' 138' ' ' PHE . 42.8 t -103.13 159.2 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.956 0.408 . . . . 1.0600000000000001 111.377 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 38.4 t-20 -167.01 160.68 14.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.859 -0.609 . . . . 2.6600000000000001 109.565 179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.413 ' CH2' ' HB2' ' A' ' 198' ' ' PHE . 20.8 m95 -45.39 -61.64 1.59 Allowed 'General case' 0 C--O 1.231 0.124 0 O-C-N 122.915 0.135 . . . . 0.40000000000000002 111.023 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -43.6 -49.03 7.27 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.988 -0.625 . . . . 0.40000000000000002 112.102 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -60.15 -56.32 23.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.732 0.301 . . . . 2.5499999999999998 110.253 179.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ILE . . . . . . . . . . . . . 35.0 mt -47.18 -48.33 8.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.109 -0.496 . . . . 1.0700000000000001 110.732 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.96 -26.85 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.926 -0.579 . . . . 1.22 111.017 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.38 -64.16 0.95 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.304 -0.407 . . . . 1.0800000000000001 110.527 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PHE . . . . . 0.401 ' CD2' HG11 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -48.83 -39.66 26.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 2.1899999999999999 110.452 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PHE . . . . . 0.449 ' CZ ' ' CD1' ' A' ' 181' ' ' LEU . 0.4 OUTLIER -55.72 -49.8 72.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 2.0499999999999998 110.284 179.369 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.87 -35.51 81.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.887 -0.597 . . . . 2.21 110.684 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.405 ' HB2' ' CE2' ' A' ' 112' ' ' PHE . 0.6 OUTLIER -62.3 -53.07 60.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.471 . . . . 1.8700000000000001 110.579 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -48.3 -42.89 25.89 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.741 . . . . 0.46000000000000002 112.058 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.89 -44.58 94.41 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.639 -0.791 . . . . 0.31 111.668 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.4 t -52.97 -42.61 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.038 0.447 . . . . 1.55 110.327 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' MET . . . . . . . . . . . . . 15.0 mtp -75.58 -39.81 57.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.739 -0.664 . . . . 1.4299999999999999 110.841 179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -56.82 -39.7 74.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 1.3300000000000001 110.649 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -76.93 -32.64 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.128 -0.487 . . . . 1.3600000000000001 110.757 179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.16 -48.47 44.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.514 . . . . 2.3300000000000001 110.34 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.86 -35.25 66.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 1.8799999999999999 110.597 179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 15.5 t -72.09 -21.74 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.489 . . . . 1.1799999999999999 111.173 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -56.32 -58.74 6.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.894 0.378 . . . . 1.96 110.778 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.94 -74.98 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.067 -0.515 . . . . 3.6499999999999999 111.086 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -175.74 63.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.329 -0.396 . . . . 2.3399999999999999 110.983 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -149.44 43.03 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 1.8999999999999999 110.853 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -47.74 -53.73 28.86 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.002 -0.545 . . . . 1.8999999999999999 111.32 -179.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.65 -28.54 12.62 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.645 2.23 . . . . 0.96999999999999997 112.68 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 1.8 tt -50.47 -34.11 23.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.379 . . . . 2.27 111.322 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.404 HG22 ' CE2' ' A' ' 30' ' ' TRP . 4.7 m -49.16 -31.32 4.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.821 0.343 . . . . 1.1200000000000001 110.719 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -67.29 -51.22 55.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 1.72 110.032 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -60.61 -28.95 68.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.932 -0.576 . . . . 1.96 110.532 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.408 ' CD1' ' CZ3' ' A' ' 176' ' ' TRP . 7.5 mm -71.01 -61.5 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 1.1699999999999999 110.39 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ALA . . . . . . . . . . . . . . . -48.07 -33.15 7.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.139 0.495 . . . . 1.1599999999999999 110.118 179.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 17.9 tp -60.6 -61.88 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.623 -0.717 . . . . 1.28 110.413 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TRP . . . . . 0.408 ' CZ3' ' CD1' ' A' ' 173' ' ' ILE . 7.9 m0 -57.11 -46.65 82.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.40999999999999998 110.624 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' MET . . . . . . . . . . . . . 94.3 mtp -49.45 -36.0 21.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 1.6699999999999999 110.3 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -73.45 -38.46 65.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.907 -0.588 . . . . 1.0700000000000001 110.798 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.22 -54.27 43.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 1.6200000000000001 111.422 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' TYR . . . . . 0.434 ' CZ ' HG12 ' A' ' 134' ' ' VAL . 18.4 t80 -65.15 -57.27 9.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.477 -0.329 . . . . 2.1800000000000002 110.63 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . 0.449 ' CD1' ' CZ ' ' A' ' 151' ' ' PHE . 7.2 tt -43.13 -45.49 5.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.812 -0.631 . . . . 1.4299999999999999 111.66 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -79.35 -35.4 40.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.029 0.442 . . . . 2.46 111.232 -179.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -71.35 -7.42 47.03 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.536 0.569 . . . . 3.54 112.536 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -143.66 -35.97 0.37 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.383 0.883 . . . . 1.1699999999999999 113.383 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . . . . . . . . . 10.0 mt -89.37 -45.66 9.31 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.042 0.386 . . . . 1.3 112.042 -178.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' HIS . . . . . . . . . . . . . 7.1 t60 -46.39 -31.48 2.66 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.744 0.306 . . . . 2.2999999999999998 111.016 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 1.3 m -75.58 -47.32 27.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.082 0.468 . . . . 1.72 110.206 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -68.1 -29.0 67.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.688 -0.687 . . . . 0.68000000000000005 110.856 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ILE . . . . . . . . . . . . . 1.7 mt -81.7 -55.75 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.004 -0.543 . . . . 1.23 111.379 -179.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -61.12 -57.21 13.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 3.3999999999999999 111.087 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -49.38 -31.2 9.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 2.21 110.824 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -110.6 52.45 0.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 2.6000000000000001 111.131 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 102.15 -89.56 0.76 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 1.79 112.746 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 154.15 -155.78 26.4 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.804 -0.712 . . . . 0.91000000000000003 112.449 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' TRP . . . . . 0.453 ' CZ2' ' CD1' ' A' ' 14' ' ' ILE . 59.6 m95 -68.24 -31.81 71.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.376 . . . . 0.70999999999999996 110.785 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -74.23 -25.89 59.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 2.0800000000000001 110.789 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -55.47 -34.76 64.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.235 -0.439 . . . . 1.0800000000000001 110.7 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' PHE . . . . . 0.413 ' HB2' ' CH2' ' A' ' 144' ' ' TRP . 9.0 t80 -79.61 -41.97 25.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.98 -0.555 . . . . 2.0600000000000001 111.013 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.88 -26.24 39.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 1.6399999999999999 111.651 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.74 -31.73 41.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.866 0.365 . . . . 2.0600000000000001 110.881 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 13.8 mt -80.38 -27.39 38.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 1.9399999999999999 110.967 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -115.29 28.38 8.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 2.3500000000000001 111.116 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -52.58 108.71 0.74 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.887 -0.673 . . . . 1.8999999999999999 112.246 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -41.95 160.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.846 2.364 . . . . 3.1000000000000001 112.681 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.7 t -47.45 95.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 5.54 111.325 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' MET . . . . . . . . . . . . . 21.9 tpp 45.57 79.47 0.05 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.054 -0.521 . . . . 6.6699999999999999 111.209 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.212 -0.899 . . . . 8.2599999999999998 110.881 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.848 0.356 . . . . 10.949999999999999 111.227 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -179.09 74.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 7.25 111.173 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 48.03 -168.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.825 -0.702 . . . . 5.2199999999999998 112.597 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.59 31.15 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.748 0.308 . . . . 7.6100000000000003 110.867 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.727 HG22 ' HG2' ' A' ' 48' ' ' GLU . 10.7 p -101.67 -51.19 3.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 3.6600000000000001 110.9 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.42 33.53 5.08 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.758 -0.734 . . . . 2.2599999999999998 112.547 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.425 ' HB3' ' CD1' ' A' ' 195' ' ' TRP . 30.7 m-85 -48.61 144.55 4.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 1.8 110.822 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -150.4 113.81 4.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 1.9099999999999999 110.989 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASN . . . . . 0.575 ' O ' HG23 ' A' ' 15' ' ' VAL . 2.4 p30 -47.52 -30.77 3.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 2.25 111.023 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -69.39 -44.41 71.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.283 -0.417 . . . . 3.25 110.728 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -70.4 -41.24 73.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 2.4399999999999999 110.733 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ILE . . . . . 0.48 HD13 ' CH2' ' A' ' 195' ' ' TRP . 1.7 mt -56.24 -52.07 55.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.81000000000000005 111.218 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.653 HG12 ' CD1' ' A' ' 19' ' ' ILE . 41.3 t -65.63 -38.05 81.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.33000000000000002 111.072 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.1 mmt -57.74 -51.19 70.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.351 -0.386 . . . . 1.0700000000000001 110.861 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . 0.528 ' HE3' ' CD2' ' A' ' 94' ' ' HIS . 0.7 OUTLIER -63.32 -45.15 92.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 2.02 110.991 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -59.77 -61.7 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 1.22 110.678 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ILE . . . . . 0.653 ' CD1' HG12 ' A' ' 15' ' ' VAL . 92.8 mt -51.62 -45.48 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.48999999999999999 110.819 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -44.84 -66.23 0.42 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.853 -0.612 . . . . 0.62 110.945 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -49.13 -38.27 24.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 0.47999999999999998 110.398 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -58.87 -29.2 66.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 1.8400000000000001 110.73 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.465 HD23 HG22 ' A' ' 19' ' ' ILE . 2.2 mm? -89.87 -46.97 8.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.70999999999999996 109.933 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.74 -25.67 11.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 1.4399999999999999 110.913 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.88 -42.72 68.95 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.075 0.464 . . . . 2.21 109.76 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ARG . . . . . 0.582 ' NH2' HG21 ' A' ' 159' ' ' VAL . 0.9 OUTLIER -85.11 -46.28 11.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.694 -0.685 . . . . 2.5800000000000001 110.578 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.55 -2.93 6.14 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.631 -0.795 . . . . 0.98999999999999999 113.475 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 30' ' ' TRP . 1.2 t80 -68.5 109.26 3.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.117 0.459 . . . . 1.49 110.609 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -66.35 83.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.986 -0.552 . . . . 2.5800000000000001 111.373 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TRP . . . . . 0.714 ' CE2' ' HB2' ' A' ' 32' ' ' ALA . 14.0 t90 -59.91 124.5 20.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.065 -0.516 . . . . 0.84999999999999998 110.719 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -86.43 59.32 5.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.414 . . . . 2.8199999999999998 110.851 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.714 ' HB2' ' CE2' ' A' ' 30' ' ' TRP . . . -68.88 -54.19 16.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 1.46 111.182 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.33 68.91 3.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.704 -0.76 . . . . 3.27 112.496 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.64 -32.31 12.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 6.3899999999999997 110.888 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.55 74.63 6.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 7.25 110.863 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.557 HG13 ' O ' ' A' ' 36' ' ' VAL . 13.3 p -88.26 55.63 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 6.1200000000000001 111.102 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -110.42 37.81 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 7.9100000000000001 110.991 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 43.48 85.87 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.022 -0.535 . . . . 9.2599999999999998 111.382 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -102.17 91.04 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 8.5800000000000001 110.896 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.97 57.11 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 9.0299999999999994 110.939 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.86 -78.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 7.1399999999999997 110.836 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -110.4 31.99 5.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 9.0999999999999996 110.945 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 42' ' ' GLU . . . 68.76 151.4 0.13 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 6.5099999999999998 111.234 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.56 -26.47 19.86 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.766 2.31 . . . . 5.9299999999999997 112.448 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -47.7 115.53 1.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.367 -0.379 . . . . 7.5700000000000003 111.051 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.77 52.82 0.53 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.778 -0.725 . . . . 3.6800000000000002 112.434 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.5 p -47.38 -31.65 4.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 3.75 111.111 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.727 ' HG2' HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -50.97 -73.17 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 3.5099999999999998 110.887 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 47.3 p -77.89 7.39 6.02 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.035 0.754 . . . . 1.5900000000000001 113.035 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.07 -48.69 13.9 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.288 -0.634 . . . . 2.2799999999999998 109.288 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 48' ' ' GLU . 7.5 p -50.36 -33.67 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.057 -0.974 . . . . 1.49 110.545 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.9 t -75.12 -43.64 44.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.68 -0.691 . . . . 0.58999999999999997 111.202 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . 0.528 ' CD2' ' HE3' ' A' ' 17' ' ' LYS . 18.4 m80 -54.08 -60.63 3.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.958 0.409 . . . . 1.76 110.581 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 95' ' ' LEU . 3.0 mt -47.96 -32.36 6.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.954 -0.567 . . . . 2.1400000000000001 110.963 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.509 HG22 ' CE2' ' A' ' 198' ' ' PHE . 3.1 m -74.32 -57.58 3.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 1.0600000000000001 111.002 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.4 -60.31 3.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.344 -0.389 . . . . 0.52000000000000002 111.034 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.62 -57.47 8.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 3.3599999999999999 110.967 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -59.7 -61.35 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 2.3100000000000001 110.992 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.93 -61.1 2.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.83999999999999997 111.237 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . 0.536 ' HA2' HG13 ' A' ' 148' ' ' VAL . . . -44.51 -50.75 8.12 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.144 -0.55 . . . . 1.24 113.198 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -63.91 -27.88 69.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.076 0.438 . . . . 2.1800000000000002 110.272 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.57 -43.16 77.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.089 -0.505 . . . . 1.8899999999999999 110.645 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 108' ' ' TYR . 15.6 t80 -60.28 -61.65 2.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.965 -0.561 . . . . 1.4099999999999999 110.508 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -39.49 17.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 1.55 110.785 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.54 -34.42 70.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 3.4300000000000002 110.562 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -75.93 -15.94 60.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.966 -0.561 . . . . 3.73 111.52 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' TYR . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 104' ' ' PHE . 81.3 m-85 -114.72 97.58 6.35 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.764 0.316 . . . . 2.7200000000000002 110.9 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -43.39 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 4.4100000000000001 110.898 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.58 99.24 6.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 4.6799999999999997 110.92 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.87 -50.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 2.6200000000000001 110.959 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' PHE . . . . . 0.632 ' HZ ' ' HB1' ' A' ' 149' ' ' ALA . 8.0 m-85 -102.64 -30.78 10.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 1.24 110.955 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -82.47 -54.25 5.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.75 110.926 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -50.9 -31.58 17.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 2.54 110.889 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 41.7 ttp -78.75 -32.73 46.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 1.04 110.858 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.1 t -48.97 -31.81 8.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 1.6399999999999999 110.902 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.7 t -48.6 -31.98 7.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 2.1499999999999999 110.901 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -90.55 57.82 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 2.6200000000000001 110.824 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.55 HD21 ' CE ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -148.3 85.35 1.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 1.8100000000000001 110.867 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -51.02 137.5 21.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 3.6600000000000001 110.969 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.3 101.48 12.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 2.1200000000000001 110.895 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -162.91 152.08 12.67 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 1.53 110.819 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.22 62.65 2.04 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.739 2.292 . . . . 1.9199999999999999 112.373 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -177.69 149.42 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 3.9399999999999999 110.858 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 63.9 p 48.5 31.0 2.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 2.3700000000000001 110.883 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.7 -46.0 48.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.93000000000000005 111.044 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -76.76 -31.76 57.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 2.5600000000000001 110.879 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.34 -31.27 78.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.713 -0.756 . . . . 0.45000000000000001 112.503 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.602 ' O ' HG23 ' A' ' 133' ' ' VAL . 16.9 mmt85 -83.74 -31.68 25.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.858 0.361 . . . . 2.96 110.873 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -66.7 -46.67 74.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 1.1499999999999999 110.795 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . 0.45 ' N ' ' CD1' ' A' ' 130' ' ' PHE . . . -56.97 -40.49 76.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.37 111.112 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.44 -34.58 75.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.51000000000000001 111.105 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 129' ' ' ARG . 25.8 t -70.66 -53.67 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.46999999999999997 111.351 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.456 HG12 ' CZ ' ' A' ' 180' ' ' TYR . 4.9 t -65.48 -29.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.35999999999999999 111.272 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.08 -42.7 99.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.913 0.387 . . . . 2.0299999999999998 110.178 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.54 -33.71 74.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.042 -0.526 . . . . 2.29 110.389 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LEU . . . . . 0.46 HD11 ' CZ ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -56.33 -49.55 74.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.58999999999999997 110.233 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.47 ' CD2' HG13 ' A' ' 142' ' ' VAL . 9.3 m-85 -112.23 66.17 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.066 -0.516 . . . . 1.0700000000000001 110.95 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -60.76 2.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 3.6099999999999999 110.876 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -80.88 -74.76 0.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 2.8399999999999999 110.975 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -134.35 169.09 23.19 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.67000000000000004 112.521 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 143' ' ' ASN . 42.8 t -103.13 159.2 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.956 0.408 . . . . 0.38 111.377 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.501 ' N ' HG12 ' A' ' 142' ' ' VAL . 38.4 t-20 -167.01 160.68 14.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.859 -0.609 . . . . 2.3700000000000001 109.565 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.439 ' CH2' ' HB2' ' A' ' 198' ' ' PHE . 20.8 m95 -45.39 -61.64 1.59 Allowed 'General case' 0 C--O 1.231 0.124 0 O-C-N 122.915 0.135 . . . . 0.32000000000000001 111.023 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -43.6 -49.03 7.27 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.988 -0.625 . . . . 0.34000000000000002 112.102 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -60.15 -56.32 23.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.732 0.301 . . . . 2.0 110.253 179.199 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ILE . . . . . 0.634 HD13 HD11 ' A' ' 189' ' ' ILE . 35.0 mt -47.18 -48.33 8.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.109 -0.496 . . . . 0.31 110.732 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.536 HG13 ' HA2' ' A' ' 101' ' ' GLY . 1.0 OUTLIER -61.96 -26.85 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.926 -0.579 . . . . 0.56000000000000005 111.017 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.632 ' HB1' ' HZ ' ' A' ' 112' ' ' PHE . . . -70.38 -64.16 0.95 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.304 -0.407 . . . . 0.29999999999999999 110.527 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PHE . . . . . 0.615 ' HE1' HD12 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -48.83 -39.66 26.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 1.3600000000000001 110.452 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PHE . . . . . 0.547 ' HE1' HG22 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -55.72 -49.8 72.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 1.21 110.284 179.369 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.87 -35.51 81.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.887 -0.597 . . . . 2.21 110.684 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.577 ' CE1' HG11 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -62.3 -53.07 60.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.471 . . . . 1.1599999999999999 110.579 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -48.3 -42.89 25.89 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.741 . . . . 0.46000000000000002 112.058 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.89 -44.58 94.41 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.639 -0.791 . . . . 0.28000000000000003 111.668 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.4 t -52.97 -42.61 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.038 0.447 . . . . 0.89000000000000001 110.327 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' MET . . . . . 0.55 ' CE ' HD21 ' A' ' 119' ' ' LEU . 15.0 mtp -75.58 -39.81 57.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.739 -0.664 . . . . 1.27 110.841 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.506 ' O ' HG12 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -56.82 -39.7 74.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.92000000000000004 110.649 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.582 HG21 ' NH2' ' A' ' 26' ' ' ARG . 0.4 OUTLIER -76.93 -32.64 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.128 -0.487 . . . . 0.67000000000000004 110.757 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.16 -48.47 44.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.514 . . . . 2.3300000000000001 110.34 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' SER . . . . . 0.531 ' HB3' HD13 ' A' ' 169' ' ' LEU . 0.7 OUTLIER -55.86 -35.25 66.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 1.47 110.597 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.921 HG22 ' HA ' ' A' ' 167' ' ' SER . 15.5 t -72.09 -21.74 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.489 . . . . 0.51000000000000001 111.173 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -56.32 -58.74 6.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.894 0.378 . . . . 1.5800000000000001 110.778 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.94 -74.98 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.067 -0.515 . . . . 3.2000000000000002 111.086 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -175.74 63.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.329 -0.396 . . . . 2.3399999999999999 110.983 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -149.44 43.03 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 1.4199999999999999 110.853 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' SER . . . . . 0.921 ' HA ' HG22 ' A' ' 162' ' ' VAL . 0.6 OUTLIER -47.74 -53.73 28.86 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.002 -0.545 . . . . 1.5700000000000001 111.32 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.65 -28.54 12.62 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.645 2.23 . . . . 0.70999999999999996 112.68 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.578 ' CD2' HD11 ' A' ' 173' ' ' ILE . 1.8 tt -50.47 -34.11 23.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.379 . . . . 1.71 111.322 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.743 HG13 ' O ' ' A' ' 167' ' ' SER . 4.7 m -49.16 -31.32 4.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.821 0.343 . . . . 0.42999999999999999 110.719 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -67.29 -51.22 55.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 1.72 110.032 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -60.61 -28.95 68.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.932 -0.576 . . . . 1.96 110.532 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.578 HD11 ' CD2' ' A' ' 169' ' ' LEU . 7.5 mm -71.01 -61.5 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.48999999999999999 110.39 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ALA . . . . . 0.635 ' HB2' HD12 ' A' ' 19' ' ' ILE . . . -48.07 -33.15 7.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.139 0.495 . . . . 0.38 110.118 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 17.9 tp -60.6 -61.88 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.623 -0.717 . . . . 0.54000000000000004 110.413 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TRP . . . . . 0.408 ' CZ3' ' CD1' ' A' ' 173' ' ' ILE . 7.9 m0 -57.11 -46.65 82.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.37 110.624 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' MET . . . . . 0.561 ' SD ' HG22 ' A' ' 173' ' ' ILE . 94.3 mtp -49.45 -36.0 21.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 1.5900000000000001 110.3 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -73.45 -38.46 65.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.907 -0.588 . . . . 0.47999999999999998 110.798 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.22 -54.27 43.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 1.6200000000000001 111.422 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' TYR . . . . . 0.456 ' CZ ' HG12 ' A' ' 134' ' ' VAL . 18.4 t80 -65.15 -57.27 9.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.477 -0.329 . . . . 1.3100000000000001 110.63 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.874 ' HG ' HD12 ' A' ' 185' ' ' LEU . 7.2 tt -43.13 -45.49 5.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.812 -0.631 . . . . 0.64000000000000001 111.66 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ASN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 186' ' ' HIS . 13.0 t30 -79.35 -35.4 40.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.029 0.442 . . . . 1.8100000000000001 111.232 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -71.35 -7.42 47.03 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.536 0.569 . . . . 3.0699999999999998 112.536 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 43.8 m80 -143.66 -35.97 0.37 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.383 0.883 . . . . 0.96999999999999997 113.383 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.874 HD12 ' HG ' ' A' ' 181' ' ' LEU . 10.0 mt -89.37 -45.66 9.31 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.042 0.386 . . . . 0.71999999999999997 112.042 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' HIS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 182' ' ' ASN . 11.1 t-80 -46.39 -31.48 2.66 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.744 0.306 . . . . 1.5900000000000001 111.016 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 1.3 m -75.58 -47.32 27.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.082 0.468 . . . . 1.3 110.206 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -68.1 -29.0 67.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.688 -0.687 . . . . 0.59999999999999998 110.856 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ILE . . . . . 0.634 HD11 HD13 ' A' ' 147' ' ' ILE . 1.7 mt -81.7 -55.75 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.004 -0.543 . . . . 0.46999999999999997 111.379 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLN . . . . . 0.497 ' N ' HG22 ' A' ' 189' ' ' ILE . 1.6 tt0 -61.12 -57.21 13.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 2.73 111.087 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -49.38 -31.2 9.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 2.21 110.824 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -110.6 52.45 0.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 2.46 111.131 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 102.15 -89.56 0.76 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 1.79 112.746 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 154.15 -155.78 26.4 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.804 -0.712 . . . . 0.57999999999999996 112.449 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' TRP . . . . . 0.48 ' CH2' HD13 ' A' ' 14' ' ' ILE . 59.6 m95 -68.24 -31.81 71.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.376 . . . . 0.60999999999999999 110.785 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -74.23 -25.89 59.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 2.0800000000000001 110.789 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -55.47 -34.76 64.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.235 -0.439 . . . . 0.34000000000000002 110.7 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' PHE . . . . . 0.509 ' CE2' HG22 ' A' ' 96' ' ' THR . 9.0 t80 -79.61 -41.97 25.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.98 -0.555 . . . . 1.1799999999999999 111.013 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.88 -26.24 39.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 1.02 111.651 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.74 -31.73 41.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.866 0.365 . . . . 2.0600000000000001 110.881 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 13.8 mt -80.38 -27.39 38.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 1.3100000000000001 110.967 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -115.29 28.38 8.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 1.76 111.116 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -52.58 108.71 0.74 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.887 -0.673 . . . . 1.8999999999999999 112.246 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -41.95 160.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.846 2.364 . . . . 2.8700000000000001 112.681 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.7 t -47.45 95.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 5.0899999999999999 111.325 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' MET . . . . . . . . . . . . . 21.9 tpp 45.57 79.47 0.05 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.054 -0.521 . . . . 6.1900000000000004 111.209 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.212 -0.899 . . . . 7.6299999999999999 110.881 179.99 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.848 0.356 . . . . 10.95 111.227 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ALA . . . . . . . . . . . . . . . -179.09 74.5 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 7.25 111.173 -179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 48.03 -168.56 0.11 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.825 -0.702 . . . . 5.22 112.597 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.59 31.15 1.19 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.748 0.308 . . . . 7.61 110.867 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.727 HG22 ' HG2' ' A' ' 48' ' ' GLU . 10.7 p -101.67 -51.19 3.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 3.66 110.9 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 100.42 33.53 5.08 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.758 -0.734 . . . . 2.26 112.547 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.425 ' HB3' ' CD1' ' A' ' 195' ' ' TRP . 30.7 m-85 -48.61 144.55 4.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.797 0.332 . . . . 1.8 110.822 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -150.4 113.81 4.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.274 -0.421 . . . . 1.91 110.989 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASN . . . . . 0.575 ' O ' HG23 ' A' ' 15' ' ' VAL . 2.4 p30 -47.52 -30.77 3.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 2.25 111.023 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 2.8 ttm180 -69.39 -44.41 71.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.283 -0.417 . . . . 3.25 110.728 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -70.4 -41.24 73.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 2.44 110.733 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ILE . . . . . 0.48 HD13 ' CH2' ' A' ' 195' ' ' TRP . 1.7 mt -56.24 -52.07 55.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.81 111.218 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.653 HG12 ' CD1' ' A' ' 19' ' ' ILE . 41.3 t -65.63 -38.05 81.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.244 -0.434 . . . . 0.33 111.072 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' MET . . . . . . . . . . . . . 1.1 mmt -57.74 -51.19 70.59 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.351 -0.386 . . . . 1.07 110.861 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . 0.451 ' CE ' ' CG ' ' A' ' 94' ' ' HIS . 0.7 OUTLIER -63.32 -45.15 92.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 2.02 110.991 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -59.77 -61.7 2.42 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.273 -0.421 . . . . 1.22 110.678 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ILE . . . . . 0.653 ' CD1' HG12 ' A' ' 15' ' ' VAL . 92.8 mt -51.62 -45.48 36.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.126 -0.488 . . . . 0.49 110.819 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' HIS . . . . . . . . . . . . . 15.3 t-160 -44.84 -66.23 0.42 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.853 -0.612 . . . . 0.62 110.945 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -49.13 -38.27 24.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.836 0.351 . . . . 0.48 110.398 179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 5.3 tptp -58.87 -29.2 66.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.124 -0.489 . . . . 1.84 110.73 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.465 HD23 HG22 ' A' ' 19' ' ' ILE . 2.2 mm? -89.87 -46.97 8.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.17 -0.468 . . . . 0.71 109.933 179.264 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -52.74 -25.67 11.87 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 1.44 110.913 179.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -53.88 -42.72 68.95 Favored 'General case' 0 N--CA 1.455 -0.209 0 CA-C-O 121.075 0.464 . . . . 2.21 109.76 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ARG . . . . . 0.582 ' NH2' HG21 ' A' ' 159' ' ' VAL . 0.9 OUTLIER -85.11 -46.28 11.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.694 -0.685 . . . . 2.58 110.578 179.463 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.55 -2.93 6.14 Favored Glycine 0 CA--C 1.52 0.357 0 C-N-CA 120.631 -0.795 . . . . 0.99 113.475 179.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 30' ' ' TRP . 1.2 t80 -68.5 109.26 3.63 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 117.117 0.459 . . . . 1.49 110.609 179.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -66.35 83.99 0.09 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.986 -0.552 . . . . 2.58 111.373 -179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TRP . . . . . 0.714 ' CE2' ' HB2' ' A' ' 32' ' ' ALA . 14.0 t90 -59.91 124.5 20.36 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.065 -0.516 . . . . 0.85 110.719 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -86.43 59.32 5.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.414 . . . . 2.82 110.851 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.714 ' HB2' ' CE2' ' A' ' 30' ' ' TRP . . . -68.88 -54.19 16.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 1.46 111.182 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . -86.33 68.91 3.24 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.704 -0.76 . . . . 3.27 112.496 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -49.64 -32.31 12.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.852 0.358 . . . . 6.39 110.888 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -79.55 74.63 6.2 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.171 -0.468 . . . . 7.25 110.863 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.557 ' O ' HG13 ' A' ' 36' ' ' VAL . 13.3 p -88.26 55.63 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.189 -0.459 . . . . 6.12 111.102 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -110.42 37.81 2.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.202 -0.454 . . . . 7.91 110.991 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 43.48 85.87 0.02 OUTLIER 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.022 -0.535 . . . . 9.26 111.382 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 11.8 t-20 -102.17 91.04 4.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.126 -0.488 . . . . 8.58 110.896 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.97 57.11 0.62 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 9.03 110.939 179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -49.86 -78.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.172 -0.467 . . . . 7.14 110.836 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.485 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.2 OUTLIER -110.4 31.99 5.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 9.1 110.945 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.485 ' HB3' ' O ' ' A' ' 42' ' ' GLU . . . 68.76 151.4 0.13 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.14 -0.482 . . . . 6.51 111.234 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.56 -26.47 19.86 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.766 2.31 . . . . 5.93 112.448 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 67.4 mm-40 -47.7 115.53 1.18 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.367 -0.379 . . . . 7.57 111.051 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.77 52.82 0.53 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.778 -0.725 . . . . 3.68 112.434 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 28.5 p -47.38 -31.65 4.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 3.75 111.111 -179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.727 ' HG2' HG22 ' A' ' 7' ' ' THR . 0.2 OUTLIER -50.97 -73.17 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 3.51 110.887 -179.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.403 ' O ' ' CD2' ' A' ' 94' ' ' HIS . 47.3 p -77.89 7.39 6.02 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.035 0.754 . . . . 1.59 113.035 -179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.07 -48.69 13.9 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 109.288 -0.634 . . . . 2.28 109.288 179.08 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.592 HG12 ' O ' ' A' ' 48' ' ' GLU . 7.5 p -50.36 -33.67 10.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.057 -0.974 . . . . 1.49 110.545 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.9 t -75.12 -43.64 44.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 115.68 -0.691 . . . . 0.59 111.202 -179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . 0.451 ' CG ' ' CE ' ' A' ' 17' ' ' LYS . 51.5 m-70 -54.08 -60.63 3.07 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.958 0.409 . . . . 1.76 110.581 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LEU . . . . . 0.602 HD23 ' N ' ' A' ' 95' ' ' LEU . 3.0 mt -47.96 -32.36 6.37 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.954 -0.567 . . . . 2.14 110.963 -179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.509 HG22 ' CE2' ' A' ' 198' ' ' PHE . 3.1 m -74.32 -57.58 3.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.269 -0.423 . . . . 1.06 111.002 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.4 -60.31 3.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.344 -0.389 . . . . 0.52 111.034 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -50.62 -57.47 8.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 3.36 110.967 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 40.4 tt0 -59.7 -61.35 2.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.292 -0.413 . . . . 2.31 110.992 -179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ALA . . . . . . . . . . . . . . . -46.93 -61.1 2.02 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.197 -0.456 . . . . 0.84 111.237 -179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . 0.536 ' HA2' HG13 ' A' ' 148' ' ' VAL . . . -44.51 -50.75 8.12 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 121.144 -0.55 . . . . 1.24 113.198 -179.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -63.91 -27.88 69.45 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 117.076 0.438 . . . . 2.18 110.272 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -68.57 -43.16 77.17 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.089 -0.505 . . . . 1.89 110.645 179.831 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 108' ' ' TYR . 15.6 t80 -60.28 -61.65 2.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.965 -0.561 . . . . 1.41 110.508 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.71 -39.49 17.71 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.045 -0.525 . . . . 1.55 110.785 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.54 -34.42 70.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.186 -0.461 . . . . 3.43 110.562 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 18.5 ttt180 -75.93 -15.94 60.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.966 -0.561 . . . . 3.73 111.52 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' TYR . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 104' ' ' PHE . 81.3 m-85 -114.72 97.58 6.35 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.764 0.316 . . . . 2.72 110.9 179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -43.39 56.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.168 -0.469 . . . . 4.41 110.898 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -121.58 99.24 6.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.217 -0.447 . . . . 4.68 110.92 -179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -172.87 -50.22 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 2.62 110.959 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' PHE . . . . . 0.632 ' HZ ' ' HB1' ' A' ' 149' ' ' ALA . 8.0 m-85 -102.64 -30.78 10.72 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 1.24 110.955 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ALA . . . . . . . . . . . . . . . -82.47 -54.25 5.35 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.43 . . . . 0.75 110.926 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -50.9 -31.58 17.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 2.54 110.889 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 41.7 ttp -78.75 -32.73 46.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 1.04 110.858 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 42.1 t -48.97 -31.81 8.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.193 -0.458 . . . . 1.64 110.902 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 7.7 t -48.6 -31.98 7.46 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.156 -0.474 . . . . 2.15 110.901 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -90.55 57.82 3.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 2.62 110.824 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.55 HD21 ' CE ' ' A' ' 157' ' ' MET . 0.3 OUTLIER -148.3 85.35 1.52 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 1.81 110.867 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' HIS . . . . . . . . . . . . . 1.7 m80 -51.02 137.5 21.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.187 -0.46 . . . . 3.66 110.969 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -100.3 101.48 12.49 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 2.12 110.895 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -162.91 152.08 12.67 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 1.53 110.819 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.22 62.65 2.04 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.739 2.292 . . . . 1.92 112.373 179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -177.69 149.42 0.61 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.188 -0.46 . . . . 3.94 110.858 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 63.9 p 48.5 31.0 2.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 2.37 110.883 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ALA . . . . . . . . . . . . . . . -73.7 -46.0 48.86 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.243 -0.435 . . . . 0.93 111.044 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 32.2 ttp180 -76.76 -31.76 57.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.167 -0.47 . . . . 2.56 110.879 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -62.34 -31.27 78.72 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.713 -0.756 . . . . 0.45 112.503 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.602 ' O ' HG23 ' A' ' 133' ' ' VAL . 16.9 mmt85 -83.74 -31.68 25.87 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.858 0.361 . . . . 2.96 110.873 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 131' ' ' ALA . 0.0 OUTLIER -66.7 -46.67 74.83 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 1.15 110.795 179.978 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . 0.45 ' N ' ' CD1' ' A' ' 130' ' ' PHE . . . -56.97 -40.49 76.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.37 111.112 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -61.44 -34.58 75.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.265 -0.425 . . . . 0.51 111.105 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 129' ' ' ARG . 25.8 t -70.66 -53.67 21.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 0.47 111.351 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.456 HG12 ' CZ ' ' A' ' 180' ' ' TYR . 4.9 t -65.48 -29.73 48.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.303 -0.408 . . . . 0.36 111.272 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -63.08 -42.7 99.71 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 120.913 0.387 . . . . 2.03 110.178 179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -68.54 -33.71 74.59 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.042 -0.526 . . . . 2.29 110.389 179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LEU . . . . . 0.46 HD11 ' CZ ' ' A' ' 112' ' ' PHE . 0.1 OUTLIER -56.33 -49.55 74.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.014 -0.539 . . . . 0.59 110.233 179.545 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.47 ' CD2' HG13 ' A' ' 142' ' ' VAL . 9.3 m-85 -112.23 66.17 0.64 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.066 -0.516 . . . . 1.07 110.95 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.93 -60.76 2.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 3.61 110.876 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -80.88 -74.76 0.3 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.181 -0.463 . . . . 2.84 110.975 -179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLY . . . . . . . . . . . . . . . -134.35 169.09 23.19 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.758 -0.734 . . . . 0.67 112.521 -179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' VAL . . . . . 0.501 HG12 ' N ' ' A' ' 143' ' ' ASN . 42.8 t -103.13 159.2 4.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.956 0.408 . . . . 0.38 111.377 -179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.501 ' N ' HG12 ' A' ' 142' ' ' VAL . 38.4 t-20 -167.01 160.68 14.33 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.859 -0.609 . . . . 2.37 109.565 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.439 ' CH2' ' HB2' ' A' ' 198' ' ' PHE . 20.8 m95 -45.39 -61.64 1.59 Allowed 'General case' 0 C--O 1.231 0.124 0 O-C-N 122.915 0.135 . . . . 0.32 111.023 -179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -43.6 -49.03 7.27 Favored Glycine 0 C--N 1.333 0.373 0 C-N-CA 120.988 -0.625 . . . . 0.34 112.102 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ARG . . . . . 0.44 ' O ' ' HB3' ' A' ' 149' ' ' ALA . 1.0 OUTLIER -60.15 -56.32 23.08 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.732 0.301 . . . . 2.0 110.253 179.199 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ILE . . . . . 0.634 HD13 HD11 ' A' ' 189' ' ' ILE . 35.0 mt -47.18 -48.33 8.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.109 -0.496 . . . . 0.31 110.732 179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.536 HG13 ' HA2' ' A' ' 101' ' ' GLY . 1.0 OUTLIER -61.96 -26.85 41.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.926 -0.579 . . . . 0.56 111.017 179.475 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.632 ' HB1' ' HZ ' ' A' ' 112' ' ' PHE . . . -70.38 -64.16 0.95 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.304 -0.407 . . . . 0.3 110.527 179.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PHE . . . . . 0.615 ' HE1' HD12 ' A' ' 181' ' ' LEU . 0.0 OUTLIER -48.83 -39.66 26.34 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.184 -0.462 . . . . 1.36 110.452 179.583 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PHE . . . . . 0.547 ' HE1' HG22 ' A' ' 15' ' ' VAL . 0.4 OUTLIER -55.72 -49.8 72.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.052 -0.522 . . . . 1.21 110.284 179.369 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -64.87 -35.51 81.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.887 -0.597 . . . . 2.21 110.684 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.577 ' CE1' HG11 ' A' ' 133' ' ' VAL . 0.6 OUTLIER -62.3 -53.07 60.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.165 -0.471 . . . . 1.16 110.579 179.859 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -48.3 -42.89 25.89 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.745 -0.741 . . . . 0.46 112.058 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -64.89 -44.58 94.41 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.639 -0.791 . . . . 0.28 111.668 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 2.4 t -52.97 -42.61 44.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 121.038 0.447 . . . . 0.89 110.327 179.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' MET . . . . . 0.55 ' CE ' HD21 ' A' ' 119' ' ' LEU . 15.0 mtp -75.58 -39.81 57.54 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.739 -0.664 . . . . 1.27 110.841 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.506 ' O ' HG12 ' A' ' 170' ' ' VAL . 0.0 OUTLIER -56.82 -39.7 74.67 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.92 110.649 179.948 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.582 HG21 ' NH2' ' A' ' 26' ' ' ARG . 0.4 OUTLIER -76.93 -32.64 19.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.128 -0.487 . . . . 0.67 110.757 179.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -49.16 -48.47 44.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.514 . . . . 2.33 110.34 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' SER . . . . . 0.531 ' HB3' HD13 ' A' ' 169' ' ' LEU . 0.7 OUTLIER -55.86 -35.25 66.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.028 -0.533 . . . . 1.47 110.597 179.59 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.921 HG22 ' HA ' ' A' ' 167' ' ' SER . 15.5 t -72.09 -21.74 20.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.489 . . . . 0.51 111.173 179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -56.32 -58.74 6.71 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.894 0.378 . . . . 1.58 110.778 179.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.94 -74.98 0.25 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.067 -0.515 . . . . 3.2 111.086 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -175.74 63.61 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.329 -0.396 . . . . 2.34 110.983 -179.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' MET . . . . . . . . . . . . . 2.5 mpt? -149.44 43.03 0.92 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 1.42 110.853 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' SER . . . . . 0.921 ' HA ' HG22 ' A' ' 162' ' ' VAL . 0.6 OUTLIER -47.74 -53.73 28.86 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 116.002 -0.545 . . . . 1.57 111.32 -179.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -48.65 -28.54 12.62 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.645 2.23 . . . . 0.71 112.68 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.578 ' CD2' HD11 ' A' ' 173' ' ' ILE . 1.8 tt -50.47 -34.11 23.72 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.365 -0.379 . . . . 1.71 111.322 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.743 HG13 ' O ' ' A' ' 167' ' ' SER . 4.7 m -49.16 -31.32 4.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 120.821 0.343 . . . . 0.43 110.719 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -67.29 -51.22 55.43 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 1.72 110.032 179.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -60.61 -28.95 68.91 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.932 -0.576 . . . . 1.96 110.532 179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.578 HD11 ' CD2' ' A' ' 169' ' ' LEU . 7.5 mm -71.01 -61.5 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.182 -0.463 . . . . 0.49 110.39 179.504 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ALA . . . . . 0.635 ' HB2' HD12 ' A' ' 19' ' ' ILE . . . -48.07 -33.15 7.68 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.139 0.495 . . . . 0.38 110.118 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LEU . . . . . . . . . . . . . 17.9 tp -60.6 -61.88 2.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.623 -0.717 . . . . 0.54 110.413 179.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TRP . . . . . 0.408 ' CZ3' ' CD1' ' A' ' 173' ' ' ILE . 7.9 m0 -57.11 -46.65 82.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.37 110.624 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' MET . . . . . 0.561 ' SD ' HG22 ' A' ' 173' ' ' ILE . 94.3 mtp -49.45 -36.0 21.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 1.59 110.3 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -73.45 -38.46 65.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.907 -0.588 . . . . 0.48 110.798 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -62.22 -54.27 43.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.018 -0.537 . . . . 1.62 111.422 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' TYR . . . . . 0.456 ' CZ ' HG12 ' A' ' 134' ' ' VAL . 18.4 t80 -65.15 -57.27 9.0 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 116.477 -0.329 . . . . 1.31 110.63 -179.814 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.874 ' HG ' HD12 ' A' ' 185' ' ' LEU . 7.2 tt -43.13 -45.49 5.47 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.812 -0.631 . . . . 0.64 111.66 -179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ASN . . . . . 0.405 ' HA ' ' HB2' ' A' ' 186' ' ' HIS . 13.0 t30 -79.35 -35.4 40.99 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.029 0.442 . . . . 1.81 111.232 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 5.8 mmt180 -71.35 -7.42 47.03 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.536 0.569 . . . . 3.07 112.536 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -143.66 -35.97 0.37 Allowed 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 113.383 0.883 . . . . 0.97 113.383 -178.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.874 HD12 ' HG ' ' A' ' 181' ' ' LEU . 10.0 mt -89.37 -45.66 9.31 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 112.042 0.386 . . . . 0.72 112.042 -178.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' HIS . . . . . 0.405 ' HB2' ' HA ' ' A' ' 182' ' ' ASN . 7.1 t60 -46.39 -31.48 2.66 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-O 120.744 0.306 . . . . 1.59 111.016 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' THR . . . . . . . . . . . . . 1.3 m -75.58 -47.32 27.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.082 0.468 . . . . 1.3 110.206 179.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' TRP . . . . . . . . . . . . . 28.8 t90 -68.1 -29.0 67.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.688 -0.687 . . . . 0.6 110.856 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ILE . . . . . 0.634 HD11 HD13 ' A' ' 147' ' ' ILE . 1.7 mt -81.7 -55.75 7.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.004 -0.543 . . . . 0.47 111.379 -179.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLN . . . . . 0.497 ' N ' HG22 ' A' ' 189' ' ' ILE . 1.6 tt0 -61.12 -57.21 13.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.238 -0.437 . . . . 2.73 111.087 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -49.38 -31.2 9.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 2.21 110.824 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASN . . . . . . . . . . . . . 51.8 t30 -110.6 52.45 0.73 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.134 -0.484 . . . . 2.46 111.131 -179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 102.15 -89.56 0.76 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.729 -0.748 . . . . 1.79 112.746 179.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLY . . . . . . . . . . . . . . . 154.15 -155.78 26.4 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.804 -0.712 . . . . 0.58 112.449 -179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' TRP . . . . . 0.48 ' CH2' HD13 ' A' ' 14' ' ' ILE . 59.6 m95 -68.24 -31.81 71.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.891 0.376 . . . . 0.61 110.785 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -74.23 -25.89 59.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.159 -0.473 . . . . 2.08 110.789 179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -55.47 -34.76 64.82 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.235 -0.439 . . . . 0.34 110.7 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' PHE . . . . . 0.509 ' CE2' HG22 ' A' ' 96' ' ' THR . 9.0 t80 -79.61 -41.97 25.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.98 -0.555 . . . . 1.18 111.013 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.88 -26.24 39.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.21 -0.45 . . . . 1.02 111.651 -179.737 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.74 -31.73 41.04 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.866 0.365 . . . . 2.06 110.881 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' LEU . . . . . . . . . . . . . 13.8 mt -80.38 -27.39 38.2 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 1.31 110.967 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -115.29 28.38 8.72 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.277 -0.42 . . . . 1.76 111.116 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . -52.58 108.71 0.74 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.887 -0.673 . . . . 1.9 112.246 179.713 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -41.95 160.24 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.846 2.364 . . . . 2.87 112.681 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 1.7 t -47.45 95.19 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.101 -0.5 . . . . 5.09 111.325 -179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' MET . . . . . . . . . . . . . 21.9 tpp 45.57 79.47 0.05 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.054 -0.521 . . . . 6.19 111.209 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ARG . . . . . . . . . . . . . 5.7 mtt-85 . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.212 -0.899 . . . . 7.63 110.881 179.99 . . . . . . . . 0 0 . 1 stop_ save_